$MRT Cashflow Statement | Understand Stock

$MRT

$1.94 -$0.01 (0.51%) Close

$MRT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 10 months to Dec 31, 2021
Cash flow from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on assets held in Trust
Depreciation and amortization
Loss on disposal of assets
Share-based, compensation, net
Interest expense-income, net
Fair value gain on derivative instrument
Foreign exchange gains
Provision for inventory obsolescence
Other non-cash
Changes in operating assets and liabilities:
Prepaid expenses
Accrued expenses
Account receivable
Inventories
Other current assets
Accounts payable
Deferred revenue
Income tax payable
Accrued expenses and other current liabilities
Net cash used in operating activities

Cash flow from investing activities
Cash deposited into trust account
Purchase of vehicles
Purchase of property and equipment
Purchase of intangible assets
Proceeds from disposal of property and equipment
Net cash used in investing activities

Cash flow from financing activities
Sale of units in public offering, net
Sale of private placement warrants to sponsor
Proceeds from issuance of Class B ordinary shares to sponsor
Repurchases of shares
Proceeds from issuance of convertible notes
Proceeds from exercise of employee share options
Repayment of convertible notes
Proceeds from term loans
Repayment of term loans
Re-purchase of warrants
Net cash generated from financing activities
(Decrease)/ increase in cash and cash equivalents

Increase/(Decrease) in cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of the year
Cash and cash equivalents at ending of the year
Deferred underwriters' discount and commissions
Initial classification of Class A ordinary shares subject to possible redemption
Remeasurement of Class A ordinary shares to redemption value
Supplemental disclosures of cash flow information:
Interest paid, net
Income taxes
Conversion of convertible notes into shares

Comments